TIE-2/VEGFR-2 kinase-IN-1
TIE-2/VEGFR-2 kinase-IN-1 is used for the synthesis of TIE-2 and/or VEGFR-2 inhibitors, extracted from patent WO2003022852, example 14. TIE-2/VEGFR-2 kinase-IN-1 is used for the study of diseases associated with inappropriate angiogenesis[1].
Product Specifications
CAS Number
453590-24-4
UNSPSC
12352005
Target
Tie; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/tie-2-vegfr-2-kinase-in-1.html
Purity
99.91
Solubility
DMSO : 6 mg/mL (ultrasonic)
Smiles
NC1=C2C(OC(C3=CC=C(OC)C=C3)=C2)=NC=N1
Molecular Formula
C13H11N3O2
Molecular Weight
241.25
References & Citations
[1]Jerry Leroy Adams, et al. Furo-and thienopyrimidine derivatives as angiogenesis inhibitors. Patent WO2003022852.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Tie2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (VU-1D9), CF640R conjugate, 0.1mg/mL
Histone H1 (AE-4), CF647 conjugate, 0.1mg/mL
TAG-72 / CA72.4 (B72.3), CF405S conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF568 conjugate, 0.1mg/mL
